Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Natl Cancer Inst ; 54(6): 1419-26, 1975 Jun.
Article in English | MEDLINE | ID: mdl-1094126

ABSTRACT

Mice homozygous for the mutation "nude" (nu/nu) are athymic and lack thymus-dependent lymphocytes. Heterozygote (nu/+) controls, which are phenotypically and immunologically normal, and (nu/nu) mice were infected with 1.0 times 10-6 colony-forming units of Phipps strain BCG. In the spleens of nu/+ mice, there was a progressive increase in number of BCG up to the second week, followed by a gradual decline. However, in the nu/nu mice, BCG growth was gradual and continuous until termination of the experiment at 5 weeks. In the lung, significant differences were not noted until after the second week, at which time the nude mice showed a rapid increase (of more than 2 log10) in the number of BCG. However, the number of BCG was not significantly greater in the livers of either group. Changes in the normal histology of the lung included a massive influx of monocytes during the first 2 weeks which peaked at day 21. In the lungs of the nu/+ mice by day 28, there was considerable granuloma formation consisting of monocytes and small lymphocytes. However, in the lungs of nu/nu animals, the granulomas were made up primarily of monocytes with a lack of small lymphocytes. Acid-fast stains confirmed the presence of large numbers of organisms in the macrophages of nu/nu mice, with gradual destruction of these phagocytic cells.


Subject(s)
BCG Vaccine , Mice, Nude/immunology , Mycobacterium Infections/immunology , Mycobacterium bovis/immunology , Animals , Granuloma/etiology , Granuloma/immunology , Granuloma/pathology , Heterozygote , Homozygote , Liver/immunology , Liver/microbiology , Lung/immunology , Lung/microbiology , Lung Diseases/pathology , Lymphocytes/immunology , Mice , Monocytes/immunology , Organ Size , Phagocytosis , Spleen/immunology , Spleen/microbiology , Time Factors
2.
Pharmacotherapy ; 21(8): 1007-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11718488

ABSTRACT

Drug-induced aseptic meningitis is a syndrome with symptoms similar to those of infectious meningitis. A 60-year-old man with a history of recurrent renal stones was admitted to the hospital with fever, chills, and mental status changes after taking levofloxacin, allopurinol, and acetazolamide. No infectious source was identified. Once home, he resumed allopurinol, and within 2 hours, he experienced the same symptoms, requiring rehospitalization. He was diagnosed with suspected meningitis from an adverse drug reaction that we believe was due to allopurinol. It is important to remember, when all other causes are ruled out, that a patient's symptoms may be a drug-induced adverse effect. Drug-induced aseptic meningitis should be considered when patients with symptoms similar to those of infectious meningitis appear without infectious etiologies or cerebrospinal fluid pleocytosis, a suspected agent was recently started, and resolution of adverse effects occurs when the agent is withdrawn.


Subject(s)
Allopurinol/adverse effects , Enzyme Inhibitors/adverse effects , Meningitis, Aseptic/chemically induced , Allopurinol/therapeutic use , Diagnosis, Differential , Enzyme Inhibitors/therapeutic use , Humans , Kidney Calculi/drug therapy , Male , Meningitis, Aseptic/diagnosis , Meningitis, Bacterial/diagnosis , Middle Aged , Xanthine Oxidase/antagonists & inhibitors
4.
J Immunol ; 126(6): 2480-4, 1981 Jun.
Article in English | MEDLINE | ID: mdl-6164731

ABSTRACT

A model for studying transfer of delayed-type sensitivity to mice with cellfree materials is described. The results with a particulate antigen (Candida) and 4 soluble protein antigens (PPD, ferritin, cytochrome c, and horseradish peroxidase) suggest that the phenomenon is antigen specific. Identical preparations from the spleens of insensitive donors were not active. This murine model should facilitate characterization of the immunologic and chemical properties of transfer factor.


Subject(s)
Epitopes , Models, Biological , Transfer Factor , Animals , Antigens, Fungal , Candida albicans/immunology , Dose-Response Relationship, Immunologic , Female , Foot/immunology , Foot/pathology , Immunization, Passive , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Spleen/immunology
5.
Infect Immun ; 12(6): 1325-30, 1975 Dec.
Article in English | MEDLINE | ID: mdl-1107224

ABSTRACT

An immunosuppressed mouse model was devised to test the effects of immunopotentiators on the prevention of bacterial and fungal infections. The effects of BCG and Corynebacterium were tested against Staphylococcus aureus and Candida albicans infection. The effect of methanol-extraction residue (MER-BCG) was tested against S. aureus septicemia. CDF mice were given various doses of BCG, 1.0 mg of C. parvum, or 0.5 mg of MER intraperitoneally at varying intervals before injection of an intravenous bacterial challenge. Four days before challenge, 300 mg of cyclophosphamide per ml was given intraperitoneally. BCG (106 colony-forming units) reduced mortality due to S.aureus at pretreatment intervals of 3, 7, 14, and 28 days. Isonicotinic acid hydrazide treatment elimated the protective effect of the live BCG. C. parvum was as effective as BCG against S. aureus septicemia when given 3 days before infection, but lost most of its protective effect after that time. MER protected at doses as small as 0.25 mg when given 25 days prior to challenge. Both BCG and C. parvum exerted a protective effect against Candida albicans infection.


Subject(s)
Antineoplastic Agents/immunology , BCG Vaccine , Candidiasis/mortality , Methanol/immunology , Mycobacterium bovis/immunology , Propionibacterium acnes/immunology , Staphylococcal Infections/mortality , Animals , Biological Products , Candida albicans/immunology , Cyclophosphamide/pharmacology , Immunosuppression Therapy , Isoniazid/pharmacology , Male , Mice , Mice, Inbred Strains , Staphylococcus aureus/immunology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL